Fosaprepitant Intravenous and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Fosaprepitant Intravenous and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Insulin glulisine
- Fosaprepitant Intravenous-Insulin Glulisine (Cartridges and Pens)
- Fosaprepitant Intravenous-Insulin Glulisine (Vials)
- Fosaprepitant Intravenous-Insulin glulisine Subcutaneous
- Fosaprepitant Intravenous-Insulin human inhaled Inhalation
- Fosaprepitant Intravenous-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Foscarnet
- Insulin glargine, recombinant Subcutaneous-Foscarnet Intravenous
- Insulin glargine, recombinant Subcutaneous-Foscarnet Sodium
- Insulin glargine, recombinant Subcutaneous-Foscavir
- Insulin glargine, recombinant Subcutaneous-Fosfomycin
- Insulin glargine, recombinant Subcutaneous-Fosfomycin Tromethamine